InvestorsHub Logo
Followers 34
Posts 4311
Boards Moderated 0
Alias Born 07/16/2014

Re: None

Wednesday, 11/02/2016 11:24:30 AM

Wednesday, November 02, 2016 11:24:30 AM

Post# of 16886
I believe that if their Parkinson's implant can prevent the onset of dyskinesia by leveling out the dosing, it will be enormously popular.




"We are continuing to advance our pipeline of products based on ProNeura and are pleased with the progress we are making in our ropinirole implant for Parkinson's disease and our T3 implant for hypothyroidism. We remain on track to submit an investigational new drug application for our ropinirole implant by the end of the year and to secure a pre-IND meeting with the FDA for our T3 implant development within that same time frame."

Titan Pharmaceuticals' (TTNP) CEO Sunil Bhonsle on Q2 2016 Results - Earnings Call Transcript $TTNP
http://www.seekingalpha.com/article/3998060

LEGEND OF ABBREVIATIONS
B = Brilacidin, the antibiotic
K = Kevetrin, the oncology drug
P = Prurisol, the psoriasis drug
SAE = Serious Adverse Event
IND = Investigational New Drug


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News